Ashkenazi Jews, sulfur gases, and ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 22, Issue 4, 1996, Pages 288-291

  Levine, Jimmy ^a   Furne, Julie K ^a   Levitt, Michael D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Ashkenazi Jews; Hydrogen sulfide; Methane; Sulfate reducing bacteria; Ulcerative colitis

Indexed keywords

HYDROGEN SULFIDE; METHANE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREATH ANALYSIS; COLON FLORA; CONTROLLED STUDY; FEMALE; HUMAN; JEW; MALE; METHANOBACTERIUM; NORMAL HUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BREATH TESTS; COLITIS, ULCERATIVE; COLON; HUMANS; HYDROGEN SULFIDE; JEWS; METHANE; MIDDLE AGED; SULFUR-REDUCING BACTERIA;

EID: 0030048548     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199606000-00009     Document Type: Article

References (37)

1. Moore WEC, Holdeman LV. Discussion of current bacteriological investigations of the relationships between intestinal flora, diet, and colon cancer. Cancer Res 1975;35:3418-20.
2. Florin THJ, Gibson GR, Neale JH, Cummings JH. A role for sulfate reducing bacteria in ulcerative colitis? Gastroenterology 1990;98:A170.
3. McKay LF, Eastwood MA, Brydon WG. Methane excretion in man - a study of breath, flatus, and faeces. Gut 1985;26:69-74.
4. Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 1987;32:267-71.
5. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104: 802-9.
6. Roediger WEW, Duncan A, Kapaniris O, Millard S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin Sci 1993;85:623-7.
7. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980;2:712-5.
8. Gibson GR, Cummings JH, Macfarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991;86:103-12.
9. Gibson GR, Cummings JH, Macfarlane GT, et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 1990;31:679-83.
10. Reiffenstein RJ, Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Ann Rev Pharmacol Toxicol 1992;32:109-34.
11. Gilat T, Ribak J, Benaroya Y, Zemishlany Z, Weissman I. Ulcerative colitis in the Jewish population of Tel-Aviv Jafo. Gastroenterology 1974;66:335-42.
12. Birnbaum D, Groen JJ, Kallner G. Ulcerative colitis among the ethnic groups in Israel. Arch Intern Med 1960;105:843-8.
13. Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of Southern Israel 1961-1985: epidemiological and clinical study. Gut 1987;28:1630-6.
14. Mayberry JF. Some aspects of the epidemiology of ulcerative colitis. Gut 1985;26:968-74.
15. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100:143-9.
16. Samuelsson S-M, Ekbom A, Zack M, Helmick CG, Adami H-O. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-controlled study. Gut 1991;32: 1526-30.
17. Gilat T, Hacohen D, Lilos P, Langman MJS. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987;22:1009-24.
18. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology 1990;99:1032-6.
19. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-10.
20. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991;35: 238-43.
21. Odom JM, Singleton R, eds. The sulfate-reducing bacteria: contemporary perspectives. New York: Springer-Verlag, 1993.
22. Windholz M, Budavari S, eds. The Merck index. 10th ed. Rahway, NJ: Merck, 1983.
23. Weisiger RA, Pinkus LM, Jakoby WB. Thiol S-methyltransferase: suggested role in detoxification of intestinal hydrogen sulfide. Biochem Pharmacol 1980;29:2885-7.
24. Jayanthi V, Probert CSJ, Mayberry JF. Epidemiology of inflammatory bowel disease. Q J Med 1991;78:5-12.
25. Christi SU, Gibson GR, Cummings JH. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992;33:1234-8.
26. Segal I, Walker AR, Lord S, Cummings JH. Breath methane and large bowel cancer risk in contrasting African populations. Gut 1988;21:951-4.
27. Gibson GR, Macfarlane GT, Cummings JH. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol 1988;65:103-11.
28. Pique JM, Pallares M, Cuso E, Bilar-Bonet J, Gassull MA. Methane production and colon cancer. Gastroenterology 1984; 87:601-5.
29. Roediger WEW, Nance S. Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis. Lipids 1990;25:646-52.
30. Ireland A, Jewell DP. 5-aminosalicylic acid (5-ASA) has no effect on butyrate metabolism in human colonic epithelial cells. Gastroenterology 1989;98:A176.
31. Chapman MAS, Grahn MF, Hutton M, Williams NS. Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis. Br J Surg 1995;82:36-8.
32. Chapman MAS, Grahn MF, Boyle MA, Hutton M, Rogers J, Williams MS. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994;35:73-6.
33. Finnic IA, Taylor BA, Rhodes JM. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut 1993;34:1552-8.
34. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS. Short-chain fatty acid enemas: a cost effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992; 35:923-7.
35. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christi S. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992;104:51-6.
36. Roediger WEW, Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol 1986;67:773-82.
37. Smith AC, Podolsky DK. Biosynthesis and secretion of human colonic mucin glycoproteins. J Clin Invest 1987;80:300-7.